BRIEF published on 06/03/2024 at 17:05, 5 months 17 days ago KindlyMD Announces Closing of $6.8 Million Initial Public Offering Healthcare Nasdaq Initial Public Offering KindlyMD WallachBeth Capital
PRESS RELEASE published on 06/03/2024 at 17:00, 5 months 17 days ago KindlyMD Announces Closing of $6.8 Million Initial Public Offering KindlyMD, Inc. announces closing of IPO, offering 1,240,910 units at $5.50/unit, grossing $6.8M. Units consist of common stock, tradable warrants, and non-tradeable warrants Warrants Units IPO Common Stock KindlyMD Inc
BRIEF published on 05/31/2024 at 17:50, 5 months 20 days ago KindlyMD Announces Pricing of $6.8 Million Initial Public Offering Warrants Healthcare Nasdaq Initial Public Offering KindlyMD
PRESS RELEASE published on 05/31/2024 at 17:45, 5 months 20 days ago KindlyMD Announces Pricing of $6.8 Million Initial Public Offering KindlyMD, Inc. announces pricing of $6.8 million IPO consisting of 1,240,910 units with shares and warrants. Underwriters have an option to purchase additional securities. WallachBeth Capital LLC is the Sole Bookrunner Securities IPO Underwriters Pricing KindlyMD Inc.
Published on 11/21/2024 at 14:00, 19 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 19 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 19 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 49 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 44 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours 4 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 21 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 59 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 34 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 34 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
